This inventor holds 2 USPTO granted patents and 5 published patent applications and 3 EPO patents. Top assignee: Armgo Pharma, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: **Innovative Contributions of Sandro Belvedere in Pharmaceutical Modulation**
Introduction
Sandro Belvedere is a distinguished inventor based in New York, NY, whose innovative work focuses on pharmaceutical modulators. He holds two patents that contribute significantly to the treatment of diseases associated with Ryanodine Receptor dysfunction, particularly in cardiac and musculoskeletal disorders.
Latest Patents
Belvedere's latest patents include significant advancements in crystalline forms of a Ryanodine Receptor modulator. One of his key patents, titled "Crystalline forms of a Ryanodine Receptor modulator and uses thereof," encompasses a compound known as 4-[(7-methoxy-2,3-dihydro-1,4-benzothiazepin-4(5H)yl)methyl]benzoic acid hemifumarate. This patent discusses not only the crystalline forms of the compound but also pharmaceutical compositions derived from it and their potential uses in treating diseases related to Ryanodine Receptor dysfunction.
Career Highlights
Sandro is currently associated with Armgo Pharma, Inc., a company that focuses on innovative medical solutions. His work emphasizes the importance of developing novel therapeutic strategies aimed at ameliorating serious health conditions linked to RyR dysfunction. Belvedere's contributions highlight his commitment to advancing medical science and improving patient care.
Collaborations
In his pursuit of innovation, Sandro collaborates with Pascal Taulelle, a valued coworker. Their partnership reflects a strong synergy in research and development efforts, which have been pivotal in the development of their patented formulations.
Conclusion
Sandro Belvedere's inventive spirit and continuous research efforts exemplify the vital role of innovation in medicine. His patents not only enhance our understanding of Ryanodine Receptors but also pave the way for future therapeutic advancements that hold promise for improved health outcomes. As a key figure at Armgo Pharma, Inc., his work continues to influence the pharmaceutical landscape significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile